Fig. 6 | Scientific Reports

Fig. 6

From: The serum biomarkers NSE and S100B predict intracranial complications and in-hospital survival in patients undergoing veno-venous ECMO

Fig. 6

Distribution of modified Rankin Scale scores at hospital discharge; 0 indicates no symptoms, 1 indicates no clinically significant disability, 2 minor clinical disabilities, 3 indicates moderate disability but the ability to walk unassisted, 4 moderate to severe disability, 5 severe disabilities, 6 death. Number of patients in each bracket provided as absolute number. A New onset of intracranial pathology increases the proportion of patients with unfavorable outcomes (mRS > 3). B-C Shift towards unfavorable outcomes in patients with serum levels of NSE or S100B above the calculated cut-off-levels (high NSE: NSE maximum level > 58.4 µg/l, high S100B; S100B maximum level above 1.52 µg/l).

Back to article page